Home
My Account
About Us
Forum
Contact us
الواجهة العربية
epharmaweb.com
Medical News Medical News
Aricles Articles
Events Events
Guidelines Guidelines
Videos Library Videos Library
Diseases Diseases
Follow us : facebook twitter Digg Linkedin Boxiz
Newsletter

Please select the categories you are intersted in:
News Articles Guidelines Events Videos Journals' abstracts

Latest Subscribers
Advanced Search »



Stroke: Treatment at The Scene May Be the Solution


 Stroke: Treatment at The Scene May Be the Solution

(ePharmaNews) - According to the generally accepted ‘time is brain’ concept, which summarize the idea that the main problem in stroke treatment is timing, i.e. the time from the initial call for help to treatment decision, so researchers make a huge efforts to reduce that time and suggest that using a specialized ambulance or mobile stroke unit (MSU) may be a useful solution.

In a study published Online First in The Lancet Neurology, a German researchers tested a specialized ambulance or mobile stroke unit (MSU) to assess and treat patients who had a suspected stroke at the site of the emergency. They found that the MSUs halve the time from the initial call of help to treatment decision, which could increase the number of patients eligible for the life-saving treatment, clot busters.

Currently, the only treatment for 80% of stroke which is called acute ischemic stroke (in which blood flow to an area of the brain is blocked or reduced) is thrombolysis using the clot-buster drug alteplase (recombinant tissue plasminogen activator) within 4.5 hours of symptom onset. Patients must have computed tomography (CT) scans of the brain before treatment begins to confirm that a clot is the cause of the stroke, which makes the management a time race.

The results of this study, included 100 patients, showed that prehospital treatment with those MSUs that are equipped with CT-Scan substantially reduced the median time from the emergency call to therapy decision compared with hospital care (35 min vs. 76 min). The MSU also lowered the time from symptoms onset to therapy decision time to less than an hour for 57% of patients compared with just 4% in the hospital-care group.

“The MSU strategy offers a potential solution to the medical problem of the arrival of most stroke patients at the hospital too late for treatment…and substantially breaks, to our knowledge, all reported times or stroke management”, explains the lead author of the study.

However, in secondary analyses, no significant difference was recorded in the numbers of patients who received thrombolysis or in neurological outcome. The researchers responded that this study was designed to study the MSU and not the improvement in the medical outcomes, as the number of patients in the study was a little bit small, so further studies that may shed light on the usefulness of these MSUs in saving the lives of people with strokes compared with treating them in hospital.


اضغط هنا للقراءة باللغة العربية

Prepared by: Basel AlJunaidy
Translated by: Marcell Shehwaro


Source :

ePharmaNews






Other Comments

Add a comment

You must sign in to use this servcie

Username:
Password:


facebook comments

Forgot your password


sign up

Consultants Corner

Dr. Samer Al-Jneidy

Dr. Samer Al-Jneidy Pediatrician

Dr. Talal Sabouni

Dr. Talal Sabouni UROLOGY AND KIDNEY TRANSPLANT

Dr. Tahsin Martini

Dr. Tahsin Martini Degree status: M.D. in Ophthalmology

Dr. Hani Najjar

Dr. Hani Najjar Pediatrics, Neurology

Yaser Habrawi , F.R.C.S.Ed

Yaser Habrawi , F.R.C.S.Ed Consultant Ophthalmologist

Dr . Dirar Abboud

Dr . Dirar Abboud Hepatologist – Gastroenterologist

Dr. Faisal Dibsi

Dr. Faisal Dibsi Specialist of Otolaryngology - Head and Neck Surgery

Samir Moussa M.D.

Samir Moussa M.D. ENT Specialist
Poll

Which of the following you are mostly interested in?

Cancer Research
Mental Health
Heart Disease & Diabetes
Sexual Health
Obesity and Healthy Diets
Mother & Child Health

Disclaimer : This site does not endorse or recommend any medical treatment, pharmaceuticals or brand names. More Details